drugset / Trial / NCT01617538

Application of Contrast Enhance Ultrasound to Evaluate Hemodynamics Change in MCA With Moderate to Severe Stenosis

NCT01617538

Phase 1/2 Unknown 30 enrolled Capital Medical University
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Objective: To monitor and evaluate the change of intracranial hemodynamics and MCA stenosis after 24-week atorvastatin treatment using CEUS, CTA and DSA. Study design: Total 30 patients (60 arteries) will be enrolled in this study, who had MCA infarction within 6 months prior to screening, and has not received any statins treatment before stroke. Eligible patient will receive atorvastatin 40mg treatment for 24 weeks. Hemodynamics changes and MCA stenosis will be evaluated using CEUS at baseline, 3-month,and 6-month. MCA stenosis, bloodstream velocity, as well as clinical symptoms will be assessed at each visit and compared to baseline.

Timeline

Start
2012-01
Primary completion
2013-03
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 40 mg

Indications

No indication recorded.